FDA Issues Draft Guidance on Nanomaterial Drug Development

Drug GMP Report
A A
The FDA released a draft guidance for the development of drugs that use nanomaterials, emphasizing that quality, efficacy and safety of products containing nanomaterials can be sensitive to the production environment and manufacturing process.

To View This Article:

Login

Subscribe To Drug GMP Report